🇺🇸 FDA
Patent

US 9611330

Compositions and methods for cancer and cancer stem cell detection and elimination

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 9611330 (Compositions and methods for cancer and cancer stem cell detection and elimination) held by The Regents of the University of California expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7105, A61K31/713, A61K38/00, A61P